A research team has developed an advanced delivery system that transports gene-editing tools based on the CRISPR/Cas9 gene-editing system into living cells with significantly greater efficiency than ...

Luigi Naldini and Franco Locatelli. In this insightful interview, leading experts in gene therapy, Franco Locatelli ...

Through CRISPR-Cas9 gene editing and single-cell analysis, they zeroed in on a gene named Zeb2.

To grow, cancer tumors must hijack the immune system for their needs. One of the main tricks that most tumors use is to ...

A research team from Helmholtz Munich and the Technical University of Munich has developed an advanced delivery system that ...

In a remarkable medical breakthrough, researchers from Israel, the United States, and China—led by the Weizmann Institute of Science—have developed an innovative genetic method that transforms ...

Four leading companies CTMC, Iovance Therapeutics, KSQ, and TILT Biotherapeutics prognosticate coming successes of new technology approaches to better tumor-infiltrating lymphocyte activities.

The researchers found that Zeb2 acts as a master switch. When the gene is active, it turns macrophages into cancer supporters ...

CRISPR-Cas9 genome editing exploits the CRISPR-Cas system to modify a genome in a targeted manner. Guided by RNA, the Cas9 endonuclease breaks DNA at a target sequence. Imprecise repair of the ...

CRISPR-Cas9 gene editing technology has emerged as one of the most transformative advancements in medicine and biotechnology.